Ali M. Al-Bahar
Research Subjects
Research Interests
Ali M. Al-Bahar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abdulmonem A. Abuzaid
Medical Microbiology Department, Security Forces Hospital Programme, Dammam 32314, Saudi Arabia
1 shared publication - Abdulmonem Ali Alsaleh
Blood and Cancer Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs (MNG-HA), Riyadh 11481, Saudi Arabia
1 shared publication - Abeer N. Alshukairiis
College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia
1 shared publication - Ali A. Rabaan
Alfaisal University
1 shared publication - Hani M. Al-Afghani
Laboratory Department, Security Forces Hospital, Makkah 24269, Saudi Arabia
1 shared publication - Hawra Albayat
Infectious Disease Department, King Saud Medical City, Riyadh 7790, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 26 June 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (7) , 1826
A Comprehensive Review on Monkeypox Viral Disease with Potential Diagnostics and Therapeutic Options
The purpose of this review is to give an up-to-date, thorough, and timely overview of monkeypox (Mpox), a severe infectious viral disease. Furthermore, this review provides an up-to-date treatment option for Mpox. The monkeypox virus (MPXV) has remained the most virulent poxvirus for humans since the elimination of smallpox approximately 41 years ago, with distribution mainly in central and west Africa. Mpox in humans is a zoonotically transferred disease that results in symptoms like those of smallpox. It had spread throughout west and central Africa when it was first diagnosed in the Republic of Congo in 1970. Mpox has become a major threat to global health security, necessitating a quick response by virologists, veterinarians, public health professionals, doctors, and researchers to create high-efficiency diagnostic tests, vaccinations, antivirals, and other infection control techniques. The emergence of epidemics outside of Africa emphasizes the disease’s global significance. A better understanding of Mpox’s dynamic epidemiology may be attained by increased surveillance and identification of cases.
- 26 June 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (7) , 1826
Open AccessA Comprehensive Review on Monkeypox Viral Disease with Potential Diagnostics and Therapeutic Options
The purpose of this review is to give an up-to-date, thorough, and timely overview of monkeypox (Mpox), a severe infectious viral disease. Furthermore, this review provides an up-to-date treatment option for Mpox. The monkeypox virus (MPXV) has remained the most virulent poxvirus for humans since the elimination of smallpox approximately 41 years ago, with distribution mainly in central and west Africa. Mpox in humans is a zoonotically transferred disease that results in symptoms like those of smallpox. It had spread throughout west and central Africa when it was first diagnosed in the Republic of Congo in 1970. Mpox has become a major threat to global health security, necessitating a quick response by virologists, veterinarians, public health professionals, doctors, and researchers to create high-efficiency diagnostic tests, vaccinations, antivirals, and other infection control techniques. The emergence of epidemics outside of Africa emphasizes the disease’s global significance. A better understanding of Mpox’s dynamic epidemiology may be attained by increased surveillance and identification of cases.